Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T

por Crees, Zachary D., Ghobadi, Armin
Publicado 2021

T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions

por Russler-Germain, David A., Ghobadi, Armin
Publicado 2023

Hematopoeitic Cell Transplantation and CAR T-Cell Therapy: Complements or Competitors?

por Goldsmith, Scott R., Ghobadi, Armin, DiPersio, John F.
Publicado 2020

Donor-Derived Smoldering Multiple Myeloma following a Hematopoietic Cell Transplantation for AML

por Fakhri, Bita, Fiala, Mark, Slade, Michael, Westervelt, Peter, Ghobadi, Armin
Publicado 2017

A systematic framework for predictive biomarkers in immune effector cell-associated neurotoxicity syndrome

por Butt, Omar H., Zhou, Alice Y., Ances, Beau M., DiPersio, John F., Ghobadi, Armin
Publicado 2023

CLRM-10. THE INTER-RELATIONSHIP BETWEEN MULTI-MODAL LONGITUDINAL BIOMARKERS OF NEURAL DAMAGE, INFLAMMATION, AND COGNITION AFTER CAR T CELLULAR THERAPY: A SINGLE-CENTER PROSPECTIVE...

por Butt, Omar, Zhou, Alice, Lee, Ken, Wu, Gregory, Song, Sheng-Kwei, Campian, Jian, DiPersio, John, Ances, Beau, Ghobadi, Armin
Publicado 2021

Biomarkers associated with blinatumomab outcomes in acute lymphoblastic leukemia

por Wei, Andrew H., Ribera, Josep-Maria, Larson, Richard A., Ritchie, David, Ghobadi, Armin, Chen, Yuqi, Anderson, Abraham, Dos Santos, Cedric E., Franklin, Janet, Kantarjian, Hagop
Publicado 2021

P1390: NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN-LABEL GLOBAL PHASE3 STUDY OF TAB-CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (...

por Kris Michael, Mahadeo, Robert, Baiocchi, Amer, Beitinjaneh, Sridhar, Chaganti, Choquet, Sylvain, Dierickx, Daan, Rajani, Dinavahi, Gamelin, Laurence, Ghobadi, Armin, Norma, Guzman-Becerra, Manher, Joshi, Aditi, Mehta, Sarah, Nikiforow, Ran, Reshef, Wei, Ye, Susan, Prockop
Publicado 2023

P356: PHASE 1/2 DOSE-ESCALATION STUDY OF ANTI-CD7 ALLOGENIC CAR-T CELL IN RELAPSED OR REFRACTORY(R/R) T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOBLASTIC LYMPHOMA(T-ALL/LBL)

por Ghobadi, Armin, Aldoss, Ibrahim, Maude, Shannon, S Wayne, Alan, Bhojwani, Deepa, Bajel, Ashish, Dholaria, Bhagirathbhai, Faramand, Rawan, Mattison, Ryan, Rettig, Michael, Bakkacha, Ouiam, Muth, John, Pannunzio, Angela, Ramsey, Brett, Mcnulty, Eileen, Cooper, Matthew, Davidson-Moncada, Jan, Jacobs, Kenneth, Dipersio, John
Publicado 2023

Phase 1 Results of ZUMA-1: A Multicenter Study of KTE-C19 Anti-CD19 CAR T Cell Therapy in Refractory Aggressive Lymphoma

por Locke, Frederick L., Neelapu, Sattva S., Bartlett, Nancy L., Siddiqi, Tanya, Chavez, Julio C., Hosing, Chitra M., Ghobadi, Armin, Budde, Lihua E., Bot, Adrian, Rossi, John M., Jiang, Yizhou, Xue, Allen X., Elias, Meg, Aycock, Jeff, Wiezorek, Jeff, Go, William Y.
Publicado 2017

Assessment of Pretreatment and Posttreatment Evolution of Neurofilament Light Chain Levels in Patients Who Develop Immune Effector Cell–Associated Neurotoxicity Syndrome

por Butt, Omar H., Zhou, Alice Y., Caimi, Paolo F., Luckett, Patrick H., Wisch, Julie K., Derenoncourt, Paul-Robert, Lee, Kenneth, Wu, Gregory F., de Lima, Marcos J. G., Campian, Jian L., Frank, Matthew J., DiPersio, John F., Ghobadi, Armin, Ances, Beau M.
Publicado 2022

P1182: A PROSPECTIVE STUDY OF TCR MEASURABLE RESIDUAL DISEASE IN PERIPHERAL T-CELL LYMPHOMA

por Jacobsen, Austin, Huang, Ying, Hill, Natalie, Elias, Karina, Holman, Matthew, Gordon, Skyler, Foley, Nicole, Russler-Germain, David, Watkins, Marcus, Jacobsen, Eric D., Moskowitz, Alison, Cashen, Amanda, Fehniger, Todd A., Kahl, Brad, Ghobadi, Armin, Reagan, Beth, Fischer, Anne, Wan, Fei, Horwitz, Steven, Mehta-Shah, Neha
Publicado 2023

CS1 CAR-T targeting the distal domain of CS1 (SLAMF7) shows efficacy in high tumor burden myeloma model despite fratricide of CD8+CS1 expressing CAR-T cells

por O’Neal, Julie, Ritchey, Julie K., Cooper, Matthew L., Niswonger, Jessica, Sofía González, L., Street, Emily, Rettig, Michael P., Gladney, Susan W., Gehrs, Leah, Abboud, Ramzi, Prior, Julie L., Haas, Gabriel J., Jayasinghe, Reyka G., Ding, Li, Ghobadi, Armin, Vij, Ravi, DiPersio, John F.
Publicado 2022

Metabolic Biomarkers Assessed with PET/CT Predict Sex-Specific Longitudinal Outcomes in Patients with Diffuse Large B-Cell Lymphoma

por Jaswal, Shama, Sanders, Vanessa, Pullarkat, Priyanka, Teja, Stephanie, Salter, Amber, Watkins, Marcus P., Atagu, Norman, Ludwig, Daniel R., Mhlanga, Joyce, Mellnick, Vincent M., Peterson, Linda R., Bartlett, Nancy L., Kahl, Brad S., Fehniger, Todd A., Ghobadi, Armin, Cashen, Amanda F., Mehta-Shah, Neha, Ippolito, Joseph E.
Publicado 2022

P367: LONG-TERM OUTCOMES OF ADULTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH BREXUCABTAGENE AUTOLEUCEL IN ZUMA-3 BY AGE, PRIOR THERAPIES, AND SUB...

por Shah, Bijal, Cassaday, Ryan D., Park, Jae H., Houot, Roche, Oluwole, Olalekan O., Logan, Aaron C., Boissel, Nicolas, Leguay, Thibaut, Bishop, Michael R., Topp, Max S., O’dwyer, Kristen M., Baer, Maria R., Schiller, Gary J., Abedi, Mehrdad, Minnema, Monique C., Stiff, Patrick, Zhou, Lang, Hadjivassileva, Tsveta, Damico Khalid, Rita, Ghobadi, Armin
Publicado 2023

Patterns of infectious complications in acute myeloid leukemia and myelodysplastic syndromes patients treated with 10‐day decitabine regimen

por Ali, Alaa M., Weisel, Daniel, Gao, Feng, Uy, Geoffrey L., Cashen, Amanda F., Jacoby, Meagan A., Wartman, Lukas D., Ghobadi, Armin, Pusic, Iskra, Romee, Rizwan, Fehniger, Todd A., Stockerl‐Goldstein, Keith E., Vij, Ravi, Oh, Stephen T., Abboud, Camille N., Schroeder, Mark A., Westervelt, Peter, DiPersio, John F., Welch, John S.
Publicado 2017

Tumor immune contexture is a determinant of anti-CD19 CAR T cell efficacy in large B cell lymphoma

por Scholler, Nathalie, Perbost, Regis, Locke, Frederick L., Jain, Michael D., Turcan, Sarah, Danan, Corinne, Chang, Edmund C., Neelapu, Sattva S., Miklos, David B., Jacobson, Caron A., Lekakis, Lazaros J., Lin, Yi, Ghobadi, Armin, Kim, Jenny J., Chou, Justin, Plaks, Vicki, Wang, Zixing, Xue, Allen, Mattie, Mike, Rossi, John M., Bot, Adrian, Galon, Jérôme
Publicado 2022

An ‘off-the-shelf’ fratricide-resistant CAR-T for the treatment of T cell hematologic malignancies

por Cooper, Matthew L., Choi, Jaebok, Staser, Karl, Ritchey, Julie K., Devenport, Jessica M., Eckardt, Kayla, Rettig, Michael P., Wang, Bing, Eissenberg, Linda G., Ghobadi, Armin, Gehrs, Leah N., Prior, Julie L., Achilefu, Samuel, Miller, Christopher A., Fronick, Catrina C., O’Neal, Julie, Gao, Feng, Weinstock, David M., Gutierrez, Alejandro, Fulton, Robert S., DiPersio, John F
Publicado 2018

Discovery of a novel genomic alteration that renders leukemic cells resistant to CD19-targeted immunotherapies

por Ghobadi, Armin, Landmann, Jack H., Carter, Alun, Cooper, Matthew L., Selli, Mehmet Emrah, Chang, Jufang, Baker, Matthew, Miller, Christopher A., Ferraro, Francesca, Chen, David Y., Smith, Amanda M., LaValle, Taylor A., Duncavage, Eric J., Chou, Justin, Tam, Victor, Benoun, Joseph M., Nater, Jenny, Scholler, Nathalie, Milletti, Francesca, Vezan, Remus, Bot, Adrian, Rossi, John M., Singh, Nathan
Publicado 2022

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

por Hong, David S., Butler, Marcus O., Pachynski, Russell K., Sullivan, Ryan, Kebriaei, Partow, Boross-Harmer, Sarah, Ghobadi, Armin, Frigault, Matthew J., Dumbrava, Ecaterina E., Sauer, Amy, Brophy, Francine, Navenot, Jean-Marc, Fayngerts, Svetlana, Wolchinsky, Zohar, Broad, Robyn, Batrakou, Dzmitry G., Wang, Ruoxi, Solis, Luisa M., Duose, Dzifa Yawa, Sanderson, Joseph P., Gerry, Andrew B., Marks, Diane, Bai, Jane, Norry, Elliot, Fracasso, Paula M.
Publicado 2022